[144] Hinge Health, Inc. SEC Filing

Rhea-AI Filing Summary

HNGE filed a Form 144 notice for the proposed public sale of 45,370 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of $2,000,817.00 for these shares and states that 37,919,155 shares of the same class are outstanding. The seller acquired 781 shares on 11/15/2025 under an employee stock purchase plan and 44,589 shares on 06/01/2025 from restricted stock units, both from the issuer. By signing, the selling holder represents they are not aware of undisclosed material adverse information about HNGE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	45370	2000817.00	37919155	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/15/2025	Employee Stock Purchase Plan	Issuer			781	11/15/2025	N/A
Common	06/01/2025	Restricted Stock Units	Issuer			44589	06/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does HNGE's latest Form 144 filing disclose?

The Form 144 for HNGE discloses a proposed sale of 45,370 shares of common stock with an aggregate market value of $2,000,817.00 through a broker on the NYSE.

How many HNGE shares are proposed to be sold and on what exchange?

The filing notes a proposed sale of 45,370 HNGE common shares, to be executed through Morgan Stanley Smith Barney LLC on the NYSE.

What is the aggregate market value of the HNGE shares in this Form 144?

The Form 144 reports an aggregate market value of $2,000,817.00 for the 45,370 HNGE common shares proposed for sale.

How many HNGE shares of this class are outstanding according to the filing?

The filing states that there are 37,919,155 shares of HNGE common stock outstanding for the class involved in the proposed sale.

How were the HNGE shares in the Form 144 acquired by the seller?

The seller acquired 781 shares on 11/15/2025 via an employee stock purchase plan and 44,589 shares on 06/01/2025 from restricted stock units, both from the issuer.

Does the HNGE Form 144 include any representation about undisclosed adverse information?

Yes. By signing, the seller represents that they do not know of any material adverse information about HNGE's current or prospective operations that has not been publicly disclosed.